Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07311044 · ClinicalTrials.gov registry record
CVD/PH and Voice Characteristics
A clinical trial of Cardiovascular Diseases and Pulmonary Hypertension, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 7,000
- Enrollment target
- 1
- Study location
NCT07311044: Recruiting study of Cardiovascular Diseases and Pulmonary Hypertension, sponsored by Mayo Clinic.
NCT07311044 is a study of Cardiovascular Diseases and Pulmonary Hypertension that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 7,000 participants, below the 26,951-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07311044, a study of Cardiovascular Diseases and Pulmonary Hypertension, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 7,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the association between patient voice signal characteristics and the presence and severity of pulmonary hypertension in patients referred for elective clinically indicated echocardiography for at Mayo Clinic MN.
Primary Outcome
A successful diagnosis of pulmonary hypertension will be confirmed by echocardiogram.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 2021-01-08 |
| Est. Completion | 2027-01 |
What NCT07311044 shows while recruiting
NCT07311044 is an observational study that tracks outcomes without assigning an intervention. Its 7,000 participants enrollment target places it among the larger protocols in the corpus, below the 26,951-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT07311044 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07311044 about?
NCT07311044 is a clinical study titled "CVD/PH and Voice Characteristics". The purpose of this study is to determine the association between patient voice signal characteristics and the presence and severity of pulmonary hypertension in patients referred for elective clinically indicated echocardiography for at Mayo Clinic MN.
What is the current status of trial NCT07311044?
This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 2021-01-08. Estimated completion is 2027-01.
What conditions does trial NCT07311044 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Pulmonary Hypertension.
Who is sponsoring clinical trial NCT07311044?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07311044 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07311044's enrollment target sits among peer trials
7,000 20th of 300 higher than 280 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07140744 · 7,000 participants · NA
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI